Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glaucoma | 6 | 2022 | 92 | 2.320 |
Why?
|
| Glaucoma, Angle-Closure | 6 | 2020 | 16 | 2.160 |
Why?
|
| Glaucoma Drainage Implants | 5 | 2023 | 12 | 2.100 |
Why?
|
| Anterior Eye Segment | 8 | 2020 | 32 | 2.070 |
Why?
|
| Iris | 6 | 2017 | 67 | 2.040 |
Why?
|
| Tomography, Optical Coherence | 10 | 2020 | 501 | 1.860 |
Why?
|
| Intraocular Pressure | 16 | 2023 | 146 | 1.480 |
Why?
|
| Laser Coagulation | 4 | 2022 | 136 | 0.850 |
Why?
|
| Ocular Hypotension | 2 | 2023 | 4 | 0.820 |
Why?
|
| Ciliary Body | 3 | 2022 | 35 | 0.790 |
Why?
|
| Gonioscopy | 7 | 2020 | 10 | 0.710 |
Why?
|
| Trabecular Meshwork | 5 | 2018 | 12 | 0.710 |
Why?
|
| Iridectomy | 2 | 2020 | 6 | 0.620 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2017 | 23 | 0.620 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2016 | 177 | 0.600 |
Why?
|
| Glaucoma, Open-Angle | 4 | 2018 | 38 | 0.600 |
Why?
|
| Eye Injuries | 1 | 2016 | 57 | 0.550 |
Why?
|
| Visual Acuity | 6 | 2018 | 873 | 0.550 |
Why?
|
| Lasers | 1 | 2016 | 198 | 0.540 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2016 | 176 | 0.500 |
Why?
|
| Cataract Extraction | 1 | 2016 | 184 | 0.490 |
Why?
|
| Tonometry, Ocular | 5 | 2018 | 32 | 0.400 |
Why?
|
| Herpesvirus 2, Human | 1 | 2011 | 24 | 0.400 |
Why?
|
| Eye Infections, Viral | 1 | 2011 | 30 | 0.390 |
Why?
|
| Eyelid Diseases | 1 | 2011 | 76 | 0.380 |
Why?
|
| Herpesvirus 1, Human | 1 | 2011 | 113 | 0.380 |
Why?
|
| Herpes Simplex | 1 | 2011 | 95 | 0.370 |
Why?
|
| Ocular Hypertension | 2 | 2023 | 24 | 0.370 |
Why?
|
| Iris Diseases | 2 | 2020 | 12 | 0.350 |
Why?
|
| Anterior Chamber | 2 | 2017 | 51 | 0.290 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2021 | 10 | 0.200 |
Why?
|
| Aniridia | 1 | 2021 | 17 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 7551 | 0.200 |
Why?
|
| Coloboma | 1 | 2021 | 43 | 0.200 |
Why?
|
| Ophthalmology | 2 | 2021 | 198 | 0.200 |
Why?
|
| Microscopy, Acoustic | 2 | 2020 | 26 | 0.190 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 49 | 0.190 |
Why?
|
| Pupil Disorders | 1 | 2020 | 22 | 0.190 |
Why?
|
| Cerebellar Ataxia | 1 | 2021 | 72 | 0.190 |
Why?
|
| Introns | 1 | 2021 | 432 | 0.180 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2021 | 137 | 0.180 |
Why?
|
| Optic Nerve Diseases | 1 | 2021 | 103 | 0.180 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.170 |
Why?
|
| Middle Aged | 15 | 2020 | 86204 | 0.170 |
Why?
|
| Port-Wine Stain | 2 | 2021 | 7 | 0.170 |
Why?
|
| Retrospective Studies | 10 | 2023 | 37905 | 0.160 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 87 | 0.160 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 191 | 0.160 |
Why?
|
| Anatomic Landmarks | 1 | 2018 | 50 | 0.160 |
Why?
|
| Limbus Corneae | 1 | 2018 | 51 | 0.160 |
Why?
|
| Equipment Failure | 1 | 2018 | 191 | 0.150 |
Why?
|
| Ophthalmologists | 1 | 2017 | 14 | 0.150 |
Why?
|
| Lasers, Solid-State | 1 | 2017 | 16 | 0.150 |
Why?
|
| Consensus | 1 | 2021 | 978 | 0.150 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 1084 | 0.140 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 206 | 0.140 |
Why?
|
| Eye Abnormalities | 1 | 2017 | 118 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 4549 | 0.140 |
Why?
|
| Aged | 13 | 2023 | 70117 | 0.140 |
Why?
|
| Male | 15 | 2021 | 123000 | 0.140 |
Why?
|
| Drainage | 1 | 2018 | 416 | 0.140 |
Why?
|
| Female | 16 | 2020 | 141928 | 0.140 |
Why?
|
| Radiologists | 1 | 2017 | 163 | 0.130 |
Why?
|
| Students, Medical | 1 | 2020 | 399 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 435 | 0.130 |
Why?
|
| Telemedicine | 1 | 2020 | 471 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2021 | 1032 | 0.110 |
Why?
|
| Retinal Vein | 1 | 2013 | 11 | 0.110 |
Why?
|
| Bevacizumab | 1 | 2017 | 938 | 0.110 |
Why?
|
| Laser Therapy | 1 | 2017 | 411 | 0.110 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2013 | 18 | 0.110 |
Why?
|
| Choroid Neoplasms | 1 | 2013 | 41 | 0.110 |
Why?
|
| Vascular Fistula | 1 | 2013 | 41 | 0.110 |
Why?
|
| Adolescent | 5 | 2017 | 31252 | 0.110 |
Why?
|
| Fluorescein Angiography | 1 | 2013 | 139 | 0.110 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 4971 | 0.100 |
Why?
|
| Hemangioma | 1 | 2013 | 154 | 0.100 |
Why?
|
| Acyclovir | 1 | 2011 | 78 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1559 | 0.100 |
Why?
|
| ROC Curve | 3 | 2020 | 1183 | 0.100 |
Why?
|
| Young Adult | 4 | 2017 | 21445 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2021 | 2403 | 0.090 |
Why?
|
| Valine | 1 | 2011 | 176 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 5539 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 1547 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 1248 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2020 | 1375 | 0.090 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2011 | 238 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 6009 | 0.080 |
Why?
|
| Neuroimaging | 2 | 2021 | 403 | 0.080 |
Why?
|
| Adult | 7 | 2020 | 77950 | 0.080 |
Why?
|
| Child | 3 | 2022 | 29154 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 1582 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8865 | 0.060 |
Why?
|
| Bimatoprost | 1 | 2023 | 2 | 0.060 |
Why?
|
| Cloprostenol | 1 | 2023 | 4 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2011 | 1230 | 0.060 |
Why?
|
| Ophthalmic Solutions | 1 | 2023 | 101 | 0.060 |
Why?
|
| Amides | 1 | 2023 | 123 | 0.060 |
Why?
|
| Recurrence | 1 | 2011 | 4758 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2017 | 5542 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2016 | 12873 | 0.050 |
Why?
|
| Mutation | 1 | 2021 | 15179 | 0.050 |
Why?
|
| Eye | 1 | 2023 | 301 | 0.050 |
Why?
|
| Facies | 1 | 2021 | 149 | 0.050 |
Why?
|
| Retinal Vessels | 1 | 2021 | 85 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 289 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 395 | 0.050 |
Why?
|
| Optic Nerve | 1 | 2021 | 133 | 0.050 |
Why?
|
| Genotype | 2 | 2018 | 4109 | 0.050 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 2265 | 0.040 |
Why?
|
| Neurology | 1 | 2021 | 113 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 338 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2021 | 298 | 0.040 |
Why?
|
| Infant | 3 | 2021 | 13310 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 4314 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2018 | 6100 | 0.040 |
Why?
|
| Body Constitution | 1 | 2018 | 35 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 860 | 0.040 |
Why?
|
| Lasers, Semiconductor | 1 | 2017 | 14 | 0.040 |
Why?
|
| Phenotype | 2 | 2021 | 6295 | 0.040 |
Why?
|
| Argon Plasma Coagulation | 1 | 2017 | 6 | 0.040 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 26 | 0.040 |
Why?
|
| Visual Fields | 1 | 2018 | 142 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 166 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 141 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2021 | 1450 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2018 | 1163 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 989 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2021 | 2283 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2022 | 14889 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 2437 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 16273 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 700 | 0.030 |
Why?
|
| Phacoemulsification | 1 | 2017 | 221 | 0.030 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2017 | 314 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 1099 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 1382 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 1533 | 0.020 |
Why?
|
| Research Design | 1 | 2018 | 1544 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2022 | 32848 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8223 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 29902 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 4744 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 5377 | 0.020 |
Why?
|
| Software | 1 | 2013 | 1321 | 0.020 |
Why?
|
| United States | 1 | 2023 | 15433 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 7702 | 0.020 |
Why?
|